blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2167126

EP2167126 - LYOPHILIZED IMMUNOGLOBULIN FORMULATIONS AND METHODS OF PREPARATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.01.2013
Database last updated on 24.08.2024
Most recent event   Tooltip25.01.2013Application deemed to be withdrawnpublished on 27.02.2013  [2013/09]
Applicant(s)For all designated states
Elan Pharmaceuticals Inc.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
[2010/13]
Inventor(s)01 / O'CONNOR, Barbara, Horsey
150 Dale Avenue
San Carlos, CA 94070 / US
02 / BUCKLEY, Shaun, E.
427 Stockton Street, 809
San Francisco, CA 94108 / US
03 / BURKE, David, J.
5957 Chabolyn Terrace
Oakland, CA 94618 / US
04 / LEHRMAN, Sherwood Russ
1731 Penny Way
Los Altos, CA 94024 / US
 [2010/26]
Former [2010/13]01 / O'CONNOR, Barbara, Horsey
150 Dale Avenue
San Carlos, CA 94070 / US
02 / BUCKLEY, Shaun, E.
427 Stockton Street, 809
San Francisco, CA 94108 / US
03 / BURKE, David, J.
5957 Chabolyn Terrace
Oakland, CA 94618 / US
04 / LEHRMAN, Russ, Sherwood
1731 Penny Way
Los Altos, CA 94024 / US
Representative(s)Schüssler, Andrea, et al
Kanzlei Huber & Schüssler
Truderinger Strasse 246
81825 München / DE
[N/P]
Former [2010/43]Schüssler, Andrea, et al
Patentanwälte Huber & Schüssler Truderinger Strasse 246
81825 München / DE
Former [2010/13]Warcoin, Jacques
Cabinet Régimbeau 20, rue de Chazelles
75847 Paris Cedex 17 / FR
Application number, filing date08771083.613.06.2008
[2010/13]
WO2008US66990
Priority number, dateUS20070929133P14.06.2007         Original published format: US 929133 P
US2008013807512.06.2008         Original published format: US 138075
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008157409
Date:24.12.2008
Language:EN
[2008/52]
Type: A1 Application with search report 
No.:EP2167126
Date:31.03.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 24.12.2008 takes the place of the publication of the European patent application.
[2010/13]
Search report(s)International search report - published on:US24.12.2008
(Supplementary) European search report - dispatched on:EP06.02.2012
ClassificationIPC:A61K39/395, C07K16/28, A61K9/19
[2012/10]
CPC:
A61K39/39591 (EP,US); A61K9/19 (EP,US); A61P37/00 (EP);
C07K16/2839 (EP,US); A61K2039/505 (EP,US); C07K2317/24 (EP,US)
Former IPC [2010/13]A61K39/395, G01N33/574
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/13]
Extension statesAL13.01.2010
BA13.01.2010
MK13.01.2010
RS13.01.2010
TitleGerman:LYOPHILISIERTE IMMUNOGLOBULIN-FORMULIERUNGEN UND HERSTELLUNGSVERFAHREN DAFÜR[2010/13]
English:LYOPHILIZED IMMUNOGLOBULIN FORMULATIONS AND METHODS OF PREPARATION[2010/13]
French:FORMULATIONS D'IMMUNOGLOBULINE LYOPHILISEES ET PROCEDES DE PREPARATION[2010/13]
Entry into regional phase13.01.2010National basic fee paid 
13.01.2010Search fee paid 
13.01.2010Designation fee(s) paid 
13.01.2010Examination fee paid 
Examination procedure13.01.2010Examination requested  [2010/13]
16.01.2010Amendment by applicant (claims and/or description)
05.09.2012Application deemed to be withdrawn, date of legal effect  [2013/09]
11.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/09]
Fees paidRenewal fee
11.06.2010Renewal fee patent year 03
13.06.2011Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.06.201205   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO03009817  (PROTEIN DESIGN LABS INC [US], et al) [A] 1-16 * abstract *;
 [X]WO2004071439  (ELAN PHARM INC [US], et al) [X] 1-16 * page 25, line 25 - page 26, line 2 *;
 [A]  - SHEREMATA W A ET AL, "A Safety and Pharmacokinetic Study of Intravenous Natalizumab in Patients with MS", NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, US, (19990301), vol. 52, no. 5, ISSN 0028-3878, pages 1072 - 1074, XP002997442 [A] 1-16 * abstract *
 [A]  - DAUGHERTY A L ET AL, "Formulation and delivery issues for monoclonal antibody therapeutics", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, vol. 58, no. 5-6, doi:10.1016/J.ADDR.2006.03.011, ISSN 0169-409X, (20060807), pages 686 - 706, (20060807), XP024892149 [A] 1-16 * the whole document * * in particular table 1 *

DOI:   http://dx.doi.org/10.1016/j.addr.2006.03.011
 [A]  - WANG W ET AL, "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, (20070101), vol. 96, no. 1, doi:10.1002/JPS.20727, ISSN 0022-3549, pages 1 - 26, XP009084505 [A] 1-16 * the whole document * * in particular table 1 *

DOI:   http://dx.doi.org/10.1002/jps.20727
International search[Y]US6306404  (LAPOSTA VINCENT JAMES [US], et al);
 [X]US2005053598  (BURKE DAVID J [US], et al);
 [Y]US2006008415  (KAISHEVA ELISABET A [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.